awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55429844-43E42E3F-19DE-4FC4-9DAF-9717BE69D00F
Q55429844-43E42E3F-19DE-4FC4-9DAF-9717BE69D00F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55429844-43E42E3F-19DE-4FC4-9DAF-9717BE69D00F
Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.
P2860
Q55429844-43E42E3F-19DE-4FC4-9DAF-9717BE69D00F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55429844-43E42E3F-19DE-4FC4-9DAF-9717BE69D00F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8b45e94a813a20fde73a8fd8006532127b40e6e6
P2860
Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria.